Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,189 | 12 | 10 | 561 | 1,834 |
| Inventories | 38 | N/A | N/A | N/A | N/A |
| TOTAL | $12,366 | $109 | $77 | $619 | $1,932 |
| Non-Current Assets | |||||
| PPE Net | 131 | 106 | 13 | 11 | 6 |
| Other Non-Current Assets | 936 | 821 | 21 | 21 | 21 |
| TOTAL | $1,067 | $927 | $34 | $32 | $27 |
| Total Assets | $13,433 | $1,036 | $110 | $651 | $1,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 531 | 1,180 | 480 | 432 | 567 |
| TOTAL | $1,162 | $3,379 | $1,458 | $616 | $707 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 632 | 493 |
| Deferred Revenues | 631 | 313 | 261 | 184 | 140 |
| Other Non-Current Liabilities | 1 | 484 | 13 | 0 | 0 |
| TOTAL | $1,224 | $2,004 | $1,764 | $1,900 | $1,449 |
| Total Liabilities | $2,386 | $5,382 | $3,222 | $2,516 | $2,155 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,689 | 25,214 | 1,046 | 22,574 | 22,441 |
| Common Shares | 59,722 | 43,185 | 40,704 | 40,447 | 40,251 |
| Retained earnings | -52,770 | -47,625 | -43,845 | -42,406 | -40,542 |
| Other shareholders' equity | 4,001 | 0 | 0 | 0 | 0 |
| TOTAL | $11,047 | $-4,347 | $-3,046 | $-1,865 | $-197 |
| Total Liabilities And Equity | $13,433 | $1,036 | $175 | $651 | $1,959 |